A Phase 1 Study of GS101 Injection

NCT07411755 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

294

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis (AD)

Interventions

DRUG: GS101 injection
DRUG: U.S. commercial Dupixent®
DRUG: CN commercial Dupixent®

Sponsor

Jiangsu Genscend Biopharmaceutical Co., Ltd